Fundz

Cytrill BV raised €85m in a Series B financing co-led by Johnson & Johnson Innovation, Forbion, and Novartis Venture Fund to advance the clinical development of its first-in-class monoclonal antibody, CIT-013.

PRIVATEDec 09, 2024

Amount Raised

€85 Million

Round Type

Series B

OssBiotechnology

Investors

Seventure PartnersForbionNovartis Venture FundCurie CapitalBomBioGeneration VenturesPureos BioventuresJohnson & Johnson Innovation

Description

Cytrill BV has successfully raised €85m in an oversubscribed Series B round. This funding will facilitate the next steps for the clinical development of CIT-013, a monoclonal antibody targeting Neutrophil Extracellular Traps (NETs).

Quick answer

Citryll raised €85 Million in a Series B round, dated December 9, 2024. Investors: Seventure Partners, Forbion, Novartis Venture Fund, Curie Capital, Bom, BioGeneration Ventures, Pureos Bioventures and Johnson & Johnson Innovation. Citryll is based in Oss, North Brabant, Netherlands.

How much did Citryll raise?
Citryll raised €85 Million in a Series B round on December 9, 2024.
Who invested in Citryll?
Seventure Partners, Forbion, Novartis Venture Fund, Curie Capital, Bom, BioGeneration Ventures, Pureos Bioventures and Johnson & Johnson Innovation are named as investors in this round.
What does Citryll do?
Citryll has translated a deep understanding of the neutrophil extracellular trap (NET) pathway to therapeutically address its central role in a broad range of inflammatory diseases.
Where is Citryll based and how big is it?
Citryll is based in Oss, North Brabant, Netherlands.
Who are the decision-makers at Citryll?
Fundz holds 1 contact at Citryll. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Citryll that raised within 45 days of this round, from Fundz verified event records.

  • MyndTec raised $100K (Pre-Seed) on January 23, 2025.
  • MED-X raised $428K on January 23, 2025.
  • Sycai Medical raised $3.1M (Seed) on January 23, 2025.
  • SVASTEK raised $231K (Seed) on January 23, 2025.
  • Nuclein raised $750K (Seed) on January 23, 2025.
  • Resynergi raised $18M on January 23, 2025.

Who to call at Citryll, and when

A new round usually means Citryll is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Citryll raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Citryll, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Citryll. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Citryll

Location

Oss, North Brabant, Netherlands

About

Citryll has translated a deep understanding of the neutrophil extracellular trap (NET) pathway to therapeutically address its central role in a broad range of inflammatory diseases. With a unique dual mode of action, the company’s lead antibody, CIT-013, has reached the clinic by demonstrating a precise and powerful ability to control NETs and NETosis. Citryll is initially developing CIT-013 as a novel drug for rheumatoid arthritis and hidradenitis suppurativa, which may serve as enabling indications for a wide spectrum of inflammatory diseases. The initial clinical trials with CIT-013 are expected to provide the foundation for a new treatment paradigm.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Citryll raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Citryll's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Citryll raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.